Medtronic (MDT) Tops Q4 EPS by 6c; Sees Larger FX Impact in FY16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- Key things to know ahead of SK Hynix’s blockbuster US listing
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
Wedbush Raised Price Target on Medtronic (MDT) Following FY16 Guidance; Maintains Neutral
June 3, 2015 9:03 AM EDTWedbush maintains a Neutral rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $79.00 (from $75.00), following Q4 results and guidance. MDT reported FY4Q15 revenue of $7.3 billion (as preannounced). Reported adjusted EPS of $1.16 was 3c ahead of the upper end of its... More
Medtronic (MDT) PT Bumped to $91 at Needham & Company Post Q4
June 2, 2015 1:08 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $90.00) following Q4 results.
Analyst Matson commented, "MDT's F4Q15 revenue was consistent with its 5/20/15 preannouncement while its EPS came in ahead of... More
